News and Commentary

Majority of HMOs still develop their own formularies internally

Though HMOs that used PBM-developed formularies increased from 10% of all HMO formularies in 2008 to 11.3% in 2009, 76.6% still develop their formularies internally. Health plans often outsource their formulary administration as a means for better benefit management.

Source: Sanofi Aventis, “Managed Care Digest Series, HMO-PPO Digest,” 2010–2011


A blueprint for high-volume, high-quality lung cancer screening that is detecting cancer earlier—and helping to save lives

Clinical Brief

Multiple Sclerosis: New Perspectives on the Patient Journey–2019 Update
Summary of an Actuarial Analysis and Report